Julio Cesar Garcia Rodriguez
Julio César García Rodríguez, in 1979, graduated in Biochemistry from Havana University. He obtained the PhD in 2002, the Titular Professor Grade in 2005, and Biotechnologist of Second Level in 2007. He is Titular Professor of the Havana Medical University. He works in the fields of basic Neuroprotection and clinical trial. Fundamentally, his results are in experimental models of stroke using erythropoietin (EPO) as neuroprotectant. He is author of more than 75 scientific publications and several books chapters. He is a pioneer in the use of EPO with low sialic acid content (Neuro-EPO) by nasal way. This new therapeutic approach could revolutionize the treatment of neurodegenerative disorders in the 21st century. He is member of the Society of Neuroscience of Cuba and received three prizes from the Academy of Sciences of Cuba (ACC). Among other distinctions, he has the Order Juan Thomas Roig from ACC and the “San Jorge” Medal from the Academic of Sciences of Ukraine.